索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]刘晋婷,谢瑞芹.甲状腺功能减退症与心房颤动[J].国际心血管病杂志,2023,06:387-391.
点击复制

甲状腺功能减退症与心房颤动(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2023年06期
页码:
387-391
栏目:
综述
出版日期:
2023-11-20

文章信息/Info

Title:
-
作者:
刘晋婷; 谢瑞芹
050004 石家庄，河北医科大学第二医院心血管内科
Author(s):
-
关键词:
心房颤动; 甲状腺功能减退症; 导管消融
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2023.06.013
文献标识码:
-
摘要:
甲状腺功能与心房颤动的发生发展密切相关，甲状腺功能减退症会影响心脏手 术后心房颤动的发生情况，并对心房颤动的治疗及预后产生影响。该文介绍甲状腺功能减退 症与心房颤动的相关性、潜在机制及心房颤动合并甲状腺功能减退症患者的治疗进展。
Abstract:
-

参考文献/References

[1] Mourtzinis G, Adamsson Eryd S, Rosengren A, et al. Primary aldosteronism and thyroid disorders in atrial fibrillation: a Swedish nationwide case-control study[J]. Eur J Prev Cardiol, 2018, 25(7):694-701.
[2] Selmer C, Olesen JB, Hansen ML, et al. The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study[J]. BMJ, 2012, 345:e7895.
[3] Kim EJ, Lyass A, Wang N, et al. Relation of hypothyroidism and incident atrial fibrillation (from the Framingham Heart Study)[J]. Am Heart J, 2014, 167(1):123-126.
[4] Huang M, Yang SY, Ge G, et al. Effects of thyroid dysfunction and the thyroid-stimulating hormone levels on the risk of atrial fibrillation: a systematic review and dose-response metaanalysis from cohort studies[J]. Endocr Pract, 2022, 28(8):822- 831.
[5] Salem JE, Shoemaker MB, Bastarache L, et al. Association of thyroid function genetic predictors with atrial fibrillation: a phenome-wide association study and inverse-variance weighted average meta-analysis[J]. JAMA Cardiol, 2019, 4(2):136-143.
[6] Ellervik C, Roselli C, Christophersen IE, et al. Assessment of the relationship between genetic determinants of thyroid function and fibrillation: a mendelian randomization study[J]. JAMA Cardiol, 2019, 4(2):144-152.
[7] Liu LM, Shen LS, Liu SY, et al. Correlations between low thyroid function and incidence of atrial fibrillation in hypertrophic obstructive cardiomyopathy[J]. Chronic Dis Transl Med, 2020, 6(1):35-45.
[8] 陈明辉. 甲状腺功能减退对稳定性心绞痛患者发生房颤的 影响[J]. 哈尔滨医药, 2015, 35(3):177-179.
[9] Worku B, Tortolani AJ, Gulkarov I, et al. Preoperative hypothyroidism is a risk factor for postoperative atrial fibrillation in cardiac surgical patients[J]. J Card Surg, 2015, 30(4):307-312.
[10] Komatsu R, Karimi NK, Zimmerman NM, et al. Biochemically diagnosed hypothyroidism and postoperative complications after cardiac surgery: a retrospective cohort analysis[J]. J Anesth, 2018, 32(5):663-672.
[11] Lin JY, Kao PC, Tsai YT, et al. Hypothyroidism is correlated with ventilator complications and longer hospital days after coronary artery bypass grafting surgery in a relatively young population: a nationwide, population-based study[J]. J Clin Med, 2022, 11(13):3881.
[12] Gerritsen RJ, van den Brom WE, Stokhof AA. Relationship between atrial fibrillation and primary hypothyroidism in the dog[J]. Vet Q, 1996, 18(2):49-51.
[13] Zhang YH, Dedkov EI, Teplitsky D, et al. Both hypothyroidism and hyperthyroidism increase atrial fibrillation inducibility in rats[J]. Circ Arrhythm Electrophysiol, 2013, 6(5):952-959.
[14] Zhang YH, Dedkov EI, Lee B 3rd, et al. Thyroid hormone replacement therapy attenuates atrial remodeling and reduces atrial fibrillation inducibility in a rat myocardial infarctionheart failure model[J]. J Card Fail, 2014, 20(12):1012-1019.
[15] Li JQ, Liu ZR, Zhao HW, et al. Alterations in atrial ion channels and tissue structure promote atrial fibrillation in hypothyroid rats[J]. Endocrine, 2019, 65(2):338-347.
[16] Liu L, Yun FX, Zhao HW, et al. Atrial sympathetic remodeling in experimental hyperthyroidism and hypothyroidism rats[J]. Int J Cardiol, 2015, 187:148-150.
[17] Guerra F, Brambatti M, Nieuwlaat R, et al. Symptomatic atrial fibrillation and risk of cardiovascular events: data from the Euro Heart Survey[J]. Europace, 2017, 19(12):1922-1929.
[18] Wei SB, Wang W, Liu N, et al. U-shaped association between serum free triiodothyronine and recurrence of atrial fibrillation after catheter ablation[J]. J Interv Card Electrophysiol, 2018, 51(3):263-270.
[19] Morishima I, Okumura K, Morita Y, et al. High-normal thyroid-stimulating hormone shows a potential causal association with arrhythmia recurrence after catheter ablation for atrial fibrillation[J]. J Am Heart Assoc, 2018, 7(14):e009158.
[20] Marouli E, Kus A, Del Greco MF, et al. Thyroid function affects the risk of stroke via atrial fibrillation: a mendelian randomization study[J]. J Clin Endocrinol Metab, 2020, 105(8):2634-2641.
[21] Dong MY, Xu CB, Zhang LS, et al. The relationship between history of thyroid diseases and risk of inhospital cardiovascular outcomes in patients with atrial fibrillation: findings from the CCC-AF (Improving Care for Cardiovascular Disease in China-Atrial Fibrillation) Project[J]. Med Clin (Barc), 2021, 156(9):421-427.
[22] 陈英伟, 郭炜华, 秦小飞, 等. 甲状腺素替代治疗对老年心 房颤动患者导管消融成功率的影响[J]. 中华老年医学杂志, 2017, 36(7):735-738.
[23] Kim KH, Mohanty S, Mohanty P, et al. Prevalence of right atrial non-pulmonary vein triggers in atrial fibrillation patients treated with thyroid hormone replacement therapy[J]. J Interv Card Electrophysiol, 2017, 49(2):111-117.
[24] Huang JH, Lin YK, Hsieh MH, et al. Thyroxine monotherapy without amiodarone enhances atrial fibrillation recurrences in amiodarone-induced hypothyroidism[J]. Int J Cardiol, 2011, 152(2):277-278.
[25] Boriani G, Blomstr?m-Lundqvist C, Hohnloser SH, et al. Safety and efficacy of dronedarone from clinical trials to realworld evidence: implications for its use in atrial fibrillation[J]. Europace, 2019, 21(12):1764-1775.
[26] Elbers LPB, Fliers E, Cannegieter SC. The influence of thyroid function on the coagulation system and its clinical Consequences[J]. J Thromb Haemost, 2018, 16(4):634-645.
[27] Goldstein SA, Green J, Huber K, et al. Characteristics and outcomes of atrial fibrillation in patients with thyroid disease (from the Aristotle trial)[J]. Am J Cardiol, 2019, 124(9):1406- 1412.
[28] Bruere H, Fauchier L, Bernard Brunet A, et al. History of thyroid disorders in relation to clinical outcomes in atrial fibrillation[J]. Am J Med, 2015, 128(1):30-37.
[29] 陈星, 肖平喜. 亚临床甲减合并阵发性房颤患者P波离 散度与心率变异性的相关性[J]. 实用心电学杂志, 2021, 30(2):117-120.
[30] Sairaku A, Nakano Y, Uchimura Y, et al. Increased left atrial pressure in non-heart failure patients with subclinical hypothyroidism and atrial fibrillation[J]. Endocr Connect, 2016, 5(3):101-106.
[31] Moutzouri E, Lyko C, Feller M, et al. Subclinical thyroid function and cardiovascular events in patients with atrial fibrillation[J]. Eur J Endocrinol, 2021, 185(3):375-385.
[32] Baumgartner C, da Costa BR, Collet TH, et al. Thyroid function within the normal range, subclinical hypothyroidism, and the risk of atrial fibrillation[J]. Circulation, 2017, 136(22):2100-2116.
[33] Park YJ, Yoon JW, Kim KI, et al. Subclinical hypothyroidism might increase the risk of transient atrial fibrillation after coronary artery bypass grafting[J]. Ann Thorac Surg, 2009, 87(6):1846-1852.
[34] Zhao D, Xu F, Yuan X, et al. Impact of subclinical hypothyroidism on outcomes of coronary bypass surgery[J]. J Card Surg, 2021, 36(4):1431-1438.
[35] Martínez-Comendador J, Marcos-Vidal JM, Gualis J, et al. Subclinical hypothyroidism might increase the risk of postoperative atrial fibrillation after aortic valve replacement[J]. Thorac Cardiovasc Surg, 2015, 64(5):427-433.
[36] Li RB, Yang XH, Zhang JD, et al. The association between subclinical thyroid dysfunction and recurrence of atrial fibrillation after catheter ablation[J]. Front Cardiovasc Med, 2022, 9:902411.
[37] Sue LY, Leung AM. Levothyroxine for the treatment of subclinical hypothyroidism and cardiovascular disease[J]. Front Endocrinol (Lausanne), 2020, 11:591588.

备注/Memo

备注/Memo:
通信作者：谢瑞芹， E-mail：xieruiqin66@163.com
更新日期/Last Update: 2023-11-20